/Companies

Myoptechs

Columbus, US · Founded 2022 · Delaware corporation · 1 employees on LinkedIn · 2 known investors

Find your way into Myoptechs

Sign up to see every warm intro you have to Myoptechs

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Myoptechs team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Myoptechs develops treatments and interventions for myopia, a progressive eye disease that causes worsening distance vision and can lead to sight-threatening complications. The company targets patients and their eye care providers seeking to reduce both short- and long-term vision complications from myopia.

Founders & leadership

PGPaul Grimm
Paul GrimmExecutive
BBBrad Beasecker
Brad BeaseckerExecutive

Board

WEWayne Embree
Wayne EmbreeBoard directorSenior Advisory Partner at Rev1 Ventures
RSRobin Sears
Robin SearsChairman of the Board

Investors · 2

Reported raises · per SEC filings

Form D private placements

$1.3M disclosed across 1 round · 2024

▶$1.3MraisedSep 2024 · 7 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Robin SearsDirector
  • Wayne EmbreeDirector
  • Paul GrimmExecutive Officer, Director
  • Brad BeaseckerExecutive Officer
Offering amount
$2M
Amount sold
$1.3M
First sale
Aug 2024
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 4

Companies working in the same space as Myoptechs.

In the news

Frequently asked questions

What does Myoptechs do?
Myoptechs develops treatments and interventions for myopia, a progressive eye disease that causes worsening distance vision and can lead to sight-threatening complications. The company targets patients and their eye care providers seeking to reduce both short- and long-term vision complications from myopia.
Who are Myoptechs's investors?
Myoptechs's investors include JobsOhio Ventures, Rev1 Ventures.
How much funding has Myoptechs raised?
Myoptechs has disclosed $1.3M raised across 1 round.
Where is Myoptechs headquartered?
Myoptechs is headquartered in Columbus, US.